Literature DB >> 24894964

Liver resection for young patients with large hepatocellular carcinoma: a single center experience from China.

Xi-yu Liu, Jiang-feng Xu1.   

Abstract

BACKGROUND: To investigate retrospectively the clinicopathological characteristics and outcomes of young patients with large hepatocellular carcinoma after hepatectomy.
METHODS: From January 2003 to December 2012, a total of 153 patients with large hepatocellular carcinoma (HCC) who received liver resection were included in the study. The clinicopathological features were analyzed retrospectively. The perioperative data were compared between those aged <40 years (the young group) and those aged >40 years (the older group). Prognostic factors and long-term survival were evaluated.
RESULTS: The young group had more hepatitis B virus-related HCC than the older group (87.2% vs 66.3%, P = 0.031). In the young group, 15 patients (21.5%) were overweight (body mass index 25 to 29.9 kg/m2) or obese (body mass index ≥30 kg/m2), and 38 patients (45.8%) were overweight or obese in the older group (P = 0.032). Other clinicopathological characteristics were similar between the two groups. The perioperative data showed that the older group had more pulmonary infection after hepatectomy. Vascular invasion and high Edmondson-Steiner grade were the independent prognostic factors for long-term survival. There was no statistical difference between the young group and the older group in overall survival and disease-free survival (P = 0.109 and P = 0.087, respectively).
CONCLUSIONS: Liver resection for young patients with large HCC was safe and efficacious and should be recommended.

Entities:  

Mesh:

Year:  2014        PMID: 24894964      PMCID: PMC4049471          DOI: 10.1186/1477-7819-12-175

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


Background

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, especially in China. HCC ranks second as a cause of cancer death overall in China [1-4]. Many studies have reported that hepatectomy could be performed satisfactorily for large HCC (>5 cm) with acceptable mortality [5-7]. However, there are few reports about the clinicopathological features and outcomes in young patients with large HCC after hepatectomy, and the significance of hepatectomy for these patients therefore remains unknown. In USA and Europe, which are not hepatitis B endemic areas, patients younger than 40 years of age with large HCC are reported to be rare;however, young patients with large HCC are not uncommon in China. To investigate the clinicopathological features as well as the long-term outcomes after hepatectomy of young patients with large HCC, we performed a retrospective study of patients with large HCC undergoing hepatectomy whose ages were younger than 40 years (the young group), compared to those patients aged above 40 years (the older group).

Methods

From January 2003 to December 2012, 153 patients with large HCC (>5 cm) were treated surgically in the Affiliated Hospital of Zhejiang University School of Medicine. Patients younger than 40 years of age (n = 70) were defined as the young group And patients aged above 40 years (n = 83) were defined as the older group. Preoperative evaluation protocol included blood biochemistry, chest radiography, liver and renal function tests, ultrasonography, contrast computed tomography and indocyanine green clearance test. Liver resection was undertaken in the patients with good cardiopulmonary and renal function, Pugh–Child’s grades A and B, and indocyanine green test at 15 min <15%. All intraoperative and postoperative complications were reviewed retrospectively through medical records. Complications (Clavien-Dindo gradesI-V) contained ascites, wound infection, pleural effusion, pulmonary infection, biliary fistula, liver failure and bleeding. Follow-up data were obtained by direct communication with patients after they underwent hepatic resection. All patients were examined for recurrence by clinical examination, alpha-fetoprotein (AFP) and ultrasonography. The follow-up period was calculated from the date of surgery to the date of either death or last follow-up. Prior informed consent was obtained from all patients and the study was approved by the Ethics Committee of Yiwu affiliated hospital of zhejiang university school of medicine. Continuous variables were expressed as mean ± SD and compared using the independent-samples t test. Categorical data analysis used the rank test or chi-square test. Survival analysis, including overall survival and disease-free survival, was estimated by the Kaplan-Meier survival method and compared using the log-rank test. Univariate and multivariate analysis by the Cox proportional hazard regression model was used to identify independent prognostic factors. All statistical analyses were performed using statistical software (SPSS 13.0 for Windows;SPSS, Chicago, IL, USA). P < 0.05 was considered to be statistically significant.

Results

Clinicopathologic features of patients with large hepatocellular carcinoma

The clinicopathologic parameters of the 153 patients with large HCC who underwent liver resection are shown in Table  1. The age of the young group was 32 ± 5 years compared to 55 ± 9 years in the older group. In the young group, 61 patients (87.2%) had positive hepatitis B in serologic test results; however, only 55 patients (66.3%) had positive hepatitis B in the older group. In the young group, 15 patients (21.4%) were overweight (body mass index (BMI) 25 to 29.9 kg/m2) or obese (BMI ≥30 kg/m2), and 38 patients (45.8%) were overweight or obese in the older group (P = 0.032). Clinicopathologic characteristics, including size of tumor, vascular invasion, tumor number, capsular formation, AFP level, liver cirrhosis, and Child-Pugh classification, showed no statistical difference between two groups.
Table 1

Clinicopathologic features of 153 patients with large hepatocellular carcinoma

VariablesMean ± SD or number (%) of patients
Young group (n = 70)Older group (n = 83) P value
Gender
 
 
 
 Female
17 (24.2%)
11(13.3%)
0.196
 Male
53 (75.8%)
72(86.7%)
Age (years)
32 ± 5
55 ± 9
<0.001
Hepatitis B status
 
 
 
 Negative
9 (12.8%)
28(33.7%)
0.031
 Positive
61 (87.2%)
55(66.3%)
Capsular formation
 
 
 
 Presence
32 (45.7%)
29(34.9%)
0.535
 Absence
38 (54.3%)
54(65.1%)
Tumor number
 
 
 
 Single
49(70.0%)
60(72.3%)
0.654
 Multiple
21(30.0%)
23(27.7%)
AFP level
 
 
 
 Negative
21 (30.0%)
32(38.5%)
0.616
 Positive
49 (70.0%)
51(61.5%)
Liver cirrhosis
 
 
 
 Absent
38 (54.3%)
44(53.0%)
0.851
 Present
32 (45.7%)
39(47.0%)
Child-Pugh classification
 
 
 
 A
56 (80.0%)
73(87.9%)
0.762
 B
14 (20.0%)
10(12.1%)
Tumor size (cm)
7.3 ± 2.1
7.9 ± 2.7
0.801
Vascular invasion
 
 
 
 Absent
37 (52.8%)
49(59.0%)
0.837
 Present
33(47.2%)
34(41.0%)
 
BMI
 
 
 
 Normal weight
55(78.6%)
45(54.2%)
0.032
 Overweight/obese15(21.4%)38(45.8%)

P values in bold indicate statistical significance between groups. AFP, alpha-fetoprotein; BMI, body mass index.

Clinicopathologic features of 153 patients with large hepatocellular carcinoma P values in bold indicate statistical significance between groups. AFP, alpha-fetoprotein; BMI, body mass index.

Perioperative data

The intraoperative and postoperative data of 153 patients with large HCC who underwent liver resection are shown in Table  2. In the young group, non-anatomical resection was used in 31 (44.3%) patients, and 39 patients (55.7%) patients had hemihepatectomy or extended hemihepatectomy. In the young group, the surgical resection margin was ≤1 cm in 34 (48.6%) patients compared to 39 (47%) patients in the older group. The time for hepatic resection was 188 ± 9 minutes in the young group compared to 193 ± 23 minutes in the older group. The volume of blood loss was 1,196 ± 638 ml in the young group with 36 (51.4%) patients losing <1,000 ml compared to 1,226 ± 768 in the older group with 39 (47%) patients losing <1,000 ml. In the young group, 32 (45.7%) patients had no blood transfusion, the length of hospital stay was 14 ± 5 days with no hospital death, and the overall postoperative complication rate was 23% (16 patients). In the older group, 30 (36.1%) patients had no blood transfusion, the length of hospital stay was 16 ± 7 days, and the overall postoperative complication rate was 22.9% (19 patients).
Table 2

Perioperative data

VariablesMean ± SD or number (%) of patients
Young group (n = 70)Older group (n = 83) P value
Type of surgical resection
 
 
 
 Non-anatomical resection
31(44.3%)
36(43.4%)
0.756
 Hemihepatectomy/extended hemihepatectomy
39(55.7%)
47(56.6%)
Surgical resection margin (cm)
 
 
 
 ≤1
34(48.6%)
39(47%)
0.936
 >1
36(51.4%)
44(53%)
 
Operative time (minutes)
188 ± 9
193 ± 23
0.673
Time for inflow occlusion (minutes)
13 ± 11
15 ± 13
0.516
Blood loss (ml)
1,196 ± 638
1,226 ± 768
0.475
 <1,000
36 (51.4%)
39(47%)
0.561
 ≥1,000
34 (48.6%)
44(53%)
 
Blood transfusion (patients)
 
 
 
 With
38 (54.3%)
53(63.9%)
0.625
 Without
32(45.7%)
30(36.1%)
 
Hospital mortality
0
1(1.2%)
0.543
Complications
16 (23.0%)
19(22.9%)
0.928
Hospital stay (days)14 ± 516 ± 70.376
Perioperative data

Postoperative complications

There was no significant difference in the overall postoperative complication rate between the two groups (23% vs 22.9%, P = 0.928; Table  3). The common complications of the two groups were ascites, wound infection, pleural effusion, pulmonary infection, biliary fistula, liver failure and bleeding. The most common complication in the young group was bleeding (8.6%), and the most common complication in the older group was pulmonary infection (13.3%). Pulmonary infection showed a significant difference between the two groups (P = 0.041). The only postoperative death was caused by liver failure in the older group (Table  3).
Table 3

Postoperative complications

 
Number (%) of patients
 
ComplicationsYoung groupOlder group P value
Overall
16 (23.0%)
19 (22.9%)
0.928
 Ascites
2 (2.8%)
1 (1.2%)
0.326
 Wound infection
2(2.8%)
2(2.4%)
0.657
 Pleural effusion
1(1.4%)
1(1.2%)
0.536
 Pulmonary infection
1(1.4%)
11(13.3%)
0.041
 Biliary fistula
2 (2.8%)
1(1.2%)
0.326
 Liver failure
2(2.8%)
1(1.2%)*
0.326
 Bleeding6(8.6%)2(2.4%)0.084

*Caused postoperative death. P values shown in bold indicate statistical significance between groups.

Postoperative complications *Caused postoperative death. P values shown in bold indicate statistical significance between groups.

Long-term survival and prognostic factors of patients with large hepatocellular carcinoma after hepatectomy

The 1-, 3-, and 5-year overall survival rates in the young group were 93%, 79% and 47%. The 1-, 3-, and 5-year disease-free survival rates in the young group were 87%, 28% and 17%. The 1-, 3-, and 5-year overall survival rates in the older group were 85%, 75% and 40%. The 1-, 3-, and 5-year disease-free survival rates in the older group were 65%, 36% and 11%. Overall survival and disease-free survival in the young group and the older group were similar (P = 0.109 and P = 0.087, respectively; Figure  1).
Figure 1

Cumulative overall and disease-free survival curves after hepatectomy of the young and older patients with large hepatocellular carcinoma.

Cumulative overall and disease-free survival curves after hepatectomy of the young and older patients with large hepatocellular carcinoma. Variables that might affect overall survival of young patients with large HCC after hepatic resection were also analyzed in this study (Table  4). Univariate analysis of the prognostic factorsfound that patients with liver cirrhosis (P = 0.045), vascular invasion (P = 0.017) and high Edmondson-Steiner grade (P = 0.036) had poorer overall survival than those without these variables. However, using multivariate analysis of the prognostic factors that predicted overall survival status, only presence of vascular invasion (P = 0.031) and high Edmondson-Steiner grade (P = 0.042) was significant (Table  4).
Table 4

Cox proportional hazard regression analyses for overall survival in young patients with large hepatocellular carcinoma after hepatectomy

Variablesn*Univariateanalysis
Multivariate analysis
HR (95% CI) P valueHR (95% CI) P value
Gender
 
 
 
 
 
 Female
17
1
 
1
 
 Male
53
0.752(0.290-3.547)
0.548
0.721(0.309-3.176)
0.408
Hepatitis B status
 
 
 
 
 
 Positive
61
1
 
1
 
 Negative
9
0.963(0.243-4.416)
0.363
0.904(0.262-3.455)
0.789
AFP level (ng/mL)
 
 
 
 
 
 Negative
21
1
 
1
 
 Positive
49
1.006(0.561-1.012)
0.053
1.069(0.972-1.108)
0.129
Number of tumors
 
 
 
 
 
 Single
49
1
 
1
 
 Multiple
21
1.351(0.739-2.146)
0.053
1.683(0.460-2.373)
0.112
Liver cirrhosis
 
 
 
 
 
 Absent
38
1
 
1
 
 Present
32
1.114(1.058-2.934)
0.045
1.137(0.866-2.798)
0.207
Child-Pugh classification
 
 
 
 
 
 A
56
1
 
1
 
 B
14
1.237(0.762-2.387)
0.508
1.119(0.428-3.946)
0.623
Vascular invasion
 
 
 
 
 
 Absent
37
1
 
1
 
 Present
33
2.112(1.037-3.896)
0.017
2.233(1.010-4.232)
0.031
Edmondson-Steiner grade
 
 
 
 
 
 Low grade (I and II)
34
1
 
1
 
 High grade (III and IV)
36
1.560(1.087-3.331)
0.036
1.747(1.235-3.346)
0.042
Surgical resection margin
 
 
 
 
 
 ≤1 cm
34
1
 
1
 
 >1 cm
36
1.339(0.234-3.642)
0.743
1.366(0.356-2.956)
0.375
Blood loss (ml)
 
 
 
 
 
 <1,000
36
1
 
1
 
 ≥1,000
34
1.036(0.424-2.986)
0.117
1.352(0.374-3.463)
0.353
Blood transfusion (ml)
 
 
 
 
 
 Without
32
1
 
1
 
 With
38
1.008(0.532-1.787)
0.733
1.453(0.834-2.564)
0.656
Complications
 
 
 
 
 
 Absent
54
1
 
1
 
 Present
16
0.986(0.330-2.675)
0.559
0.824(0.363-2.863)
0.348
BMI
 
 
 
 
 
 Normal weight
55
1
 
1
 
 Overweight/obese151.006(0.687-1.331)0.3091.250(0.909-1.671)0.326

*Number of patients. P values shown in bold indicate statistical significance between groups. AFP, alpha-fetoprotein; BMI, body mass index; HR, hazard ratio.

Cox proportional hazard regression analyses for overall survival in young patients with large hepatocellular carcinoma after hepatectomy *Number of patients. P values shown in bold indicate statistical significance between groups. AFP, alpha-fetoprotein; BMI, body mass index; HR, hazard ratio.

Discussion

Young patients with large HCC, who are rare in USA and Europe, are not uncommon at diagnosis in China. Astudy showed that 30% of HCC patients were younger than 40 years old [8]; in our cohort this ratio reached 47%. The high liver cancer rates in young patients in China largely reflect the prevalence of chronic hepatitis B virus (HBV) infection [9-11]. In this study, the young group had more HBV-related HCC than the older group (87.2% vs66.3%, P = 0.031). This implied that HCC in most young patients was caused by HBV infection. This infection may even have happened in infancy and has caused liver cirrhosis after many years. HBV infection leads to HCC [12-15]; therefore, regular examination of AFP and B ultrasound is very important for young patients with a history of hepatitis B infection. It is key for an early diagnosis and early operative treatment to improve the survival rate of young HCC patients. In the older group, there may be other factors involved. In the young group, 15 patients (21.4%) were overweight (BMI 25 to 29.9 kg/m2) or obese (BMI ≥30 kg/m2), compared to 38 patients (45.8%) in the older group (P = 0.032). It is implied that non-alcoholic fatty liver diseases, which are associated with obesity, may participate in the development of HCC, especially in older patients [16-19]; therefore, we must pay more attention to the older patients who are overweight or obese. Our study showed that hepatic resection for large HCC could be performed with an acceptable mortality rate and postoperative complication rates. The perioperative data were similar between two two groups, except that the older group had more pulmonary infection after hepatectomy. This implies that hepatectomy for young patients with large HCC is safe. We also found that the cumulative overall and disease-free survival curves after hepatectomy showed no statistical difference between the young and the older groups. This implies that hepatic resection for young patients with large HCC is efficacious.

Conclusion

In conclusion, the clinicopathologic characteristics and the outcome for young patients with large HCC after liver resection were similar to that of the older patients, except for differences in infection through HBV and BMI. Liver resection for young patients with large HCC is safe and efficacious and should be recommended.

Abbreviations

AFP: alpha-fetoprotein; BMI: body mass index; HBV: hepatitis B virus; HCC: hepatocellular carcinoma.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

XYL and JFX carried out the data collection and analysis, drafted the manuscript. Both authors read and approved the final manuscript.
  18 in total

1.  Hepatic resection for huge (>15 cm) multinodular HCC with macrovascular invasion.

Authors:  Jiwei Huang; Roberto Hernandez-Alejandro; Kristopher P Croome; Yong Zeng; Hong Wu; Zheyu Chen
Journal:  J Surg Res       Date:  2012-05-15       Impact factor: 2.192

2.  Hepatectomy for huge hepatocellular carcinoma: single institute's experience.

Authors:  Lianyue Yang; Jiangfeng Xu; Dipeng Ou; Wei Wu; Zhijun Zeng
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

3.  Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.

Authors:  Oscar C Araujo; José J F Barros; Kycia M do Ó; Letícia C Nabuco; Charles A Luz; Renata M Perez; Christian Niel; Cristiane A Villela-Nogueira; Natalia M Araujo
Journal:  J Med Virol       Date:  2013-11-06       Impact factor: 2.327

Review 4.  HBV infection and hepatocellular carcinoma.

Authors:  Massimo Iavarone; Massimo Colombo
Journal:  Clin Liver Dis       Date:  2013-07-03       Impact factor: 6.126

Review 5.  Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein.

Authors:  M Motavaf; S Safari; M Saffari Jourshari; S M Alavian
Journal:  Acta Virol       Date:  2013       Impact factor: 1.162

Review 6.  Improving detection and treatment of liver cancer.

Authors:  Margaret G Keane; Stephen P Pereira
Journal:  Practitioner       Date:  2013 Jul-Aug

Review 7.  Primary hepatocellular carcinoma and metabolic syndrome: An update.

Authors:  Rubayat Rahman; Ghassan M Hammoud; Ashraf A Almashhrawi; Khulood T Ahmed; Jamal A Ibdah
Journal:  World J Gastrointest Oncol       Date:  2013-09-15

Review 8.  Chronic hepatitis B virus infection.

Authors:  Brian J McMahon
Journal:  Med Clin North Am       Date:  2013-10-20       Impact factor: 5.456

9.  Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China.

Authors:  Yuan Yang; Li Jin; Ying-Li He; Ke Wang; Xiao-Hua Ma; Jing Wang; Zhi Yan; Yu-Ling Feng; Yong-Qin Li; Tian-Yan Chen; Hong-Li Liu; Ying-Ren Zhao
Journal:  J Med Virol       Date:  2013-08-09       Impact factor: 2.327

10.  Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up.

Authors:  Shahnaz Sali; Seyed Moayed Alavian; Graham R Foster; Hossein Keyvani; Leila Mehrnoosh; Navid Mohammadi
Journal:  Hepat Mon       Date:  2013-07-08       Impact factor: 0.660

View more
  6 in total

1.  Outcomes of adolescent and young patients with hepatocellular carcinoma after curative liver resection: a retrospective study.

Authors:  Zheng-Yun Zhang; Jiao Guan; Xin-Ping Wang; Di-Si Hao; Zun-Qiang Zhou
Journal:  World J Surg Oncol       Date:  2022-06-21       Impact factor: 3.253

2.  Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification.

Authors:  Jiang-feng Xu; Xi-yu Liu; Shuai Wang; Huai-xi Wen
Journal:  World J Surg Oncol       Date:  2015-02-28       Impact factor: 2.754

3.  Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

Authors:  Jian-Yao Chen; Li-Ping Liu; Jiang-Feng Xu
Journal:  Onco Targets Ther       Date:  2017-01-11       Impact factor: 4.147

4.  Prognostic nomogram for hepatocellular carcinoma in adolescent and young adult patients after hepatectomy.

Authors:  Wei Zhang; Yifei Tan; Shu Shen; Li Jiang; Lunan Yan; Jiayin Yang; Bo Li; Tianfu Wen; Yong Zeng; Wen Tao Wang; Mingqing Xu
Journal:  Oncotarget       Date:  2017-05-23

5.  Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: multicentre propensity score-matching study.

Authors:  Jia-Le Pu; Zhong Chen; Lan-Qing Yao; Ji-Ye Feng; Yong-Kang Diao; Ming-Cheng Guan; Ju-Dong Li; Zheng-Liang Chen; Ya-Hao Zhou; Hong Wang; Wei-Min Gu; Jie Li; Chao Li; Ming-Da Wang; Hong Zhu; Ying-Jian Liang; Feng Shen; Timothy M Pawlik; Wan Yee Lau; Tian Yang
Journal:  BJS Open       Date:  2022-01-06

6.  The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Xiaoxiang Rong; Fang Wei; Qian Geng; Jian Ruan; Hongfen Shen; Aimin Li; Rongcheng Luo
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.